At Penn State, scientists have peered into the molecular architecture of BRD4—a protein long entangled with cancer—and found that its grip on chromosomes is more versatile, and more surprising, than the field had assumed. Using cryo-electron microscopy to resolve structures at near-atomic scale, the researchers discovered that BRD4 can anchor itself to genetic material through multiple pathways, including one that requires no chemical signal at all. This challenges a foundational assumption that had guided drug development for years, and quietly expands the map of where and how this protein op